期刊文献+

吲哚螺吡咯类衍生物的合成及其抗肿瘤细胞活性筛选

Spiro [ indoline - 3,2' - pyrrolidin ] derivatives: synthesis and the screening of anticancer activity
下载PDF
导出
摘要 目的合成一类螺环结构的4’-芳基-3’-吡啶甲酰基螺[吲噪-3,2’-吡咯啉]-2-酮化合物,并对其抗肿瘤细胞活性进行初步筛选。方法利用多组分反应方法合成吲哚螺环化合物,并采用四甲基偶氮唑盐比色(MTr)法测试其细胞活性。结果反应在2-3h内完成,产率80%~85%,产物通过光谱数据表征确认结构;并筛选了其对肝癌细胞BEL-7402、人低分化胃癌细胞BGC-823、人乳腺癌细胞MDA—MB-231的抑制活性。结论螺[吲哚-3,2’-吡咯啉]类化合物含多个活性杂环骨架,有潜在的抗肿瘤细胞活性作用。 Objectives To synthesis spiro[ indoline- 3,2' -pyrrolidinj derivatives and investigate their anticancer activities. Methods The target compounds were synthesized via multi - component reactions, and evaluated for their an- ticancer activities against human cancer cell lines by MTY assay. Results The reaction was completed within 2 - 3 hours with yields of 80% -85%. The structures of the products were determined by IR, 1H NMR spectra, and the anticancer activities against human cancer cell lines BEL -7402, BGC -823 and MDA -MB -231 were tested. Conclusion The spiro[ indoline-3,2' -pyrrolidin] derivatives contain muti -heterocyelic skeletons which are expected to exhibit poten- tial biological activities.
出处 《徐州医学院学报》 CAS 2016年第6期371-373,共3页 Acta Academiae Medicinae Xuzhou
基金 江苏省大学生创新训练计划项目(201410313049Y)
关键词 吲哚螺吡咯 杂环合成 抗肿瘤细胞活性 spiro [ indoline - 3,2' - pyrrolidin ] heterocycle synthesis anticancer activity
  • 相关文献

参考文献9

  • 1Thangamani A. Regiospecific synthesis and biological evaluation ofspirooxindolopyrrolizidines via [ 3 + 2 ] cycloaddition of azomethine ylide [J]. Eur J Med Chem, 2010,45(12) :6120 -6126.
  • 2Dandia A, Singh R, Khaturia S, et al. Efficient microwave en- hanced regioselective synthesis of a series of benzimidazolyl/tri- azolyl spiro [ indole - thiazolidinones ] as potent antifungal agents and crystal structure of spiro [ 3 H - indole - 3,2' - thiazolidine ] - 3' ( 1,2,4 - triazol - 3 - yl) - 2,4' ( 1 H) - dione [ J ]. Bioorg Med Chem, 2006, 14(7): 2409-2417.
  • 3Edmondson S, Danishefsky SJ, Sepp - Lorenzino L, et al. Total synthesis of spirotryprostatin A, leading to the discovery of some biologically promising analogues [ J]. J Am Chem Soc, 1999,121 (10) :2147 - 2155.
  • 4Cui CB, Kakeya H, Osada H. Novel mammalian cell cycle inhibi- tors, cyclotroprostatins A - D, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase [ J]. Tetra- hedron, 1997,53( 1 ) :59 -72.
  • 5Potts BC, Faulkner D J, Chan JA, et al. Didemnaketals A and B, HIV - 1 protease inhibitors from the ascidian didemnum sp [J]. J Am Chem Soc, 1991,113 (16) :6321 - 6322.
  • 6Singh GS, Desta ZY. Isatins as privileged molecules in design and synthesis of spiro - fused cyclic frameworks [J]. Chem Rev, 2012,112(11) :6104 -6155.
  • 7艾歇尔T,豪普特曼S.杂环化学-结构、反应、合成与应用[M].北京:化学工业出版社,2005:346-349.
  • 8Shiri M. Indoles in multicomponent processes (MCPs) [ J ]. Chem Rev, 2012,112(6) :3508 -3549.
  • 9Li J, Wang J, Xu Z, et al. Combinatorial synthesis of functional- ized spirooxindole - pyrrolidine/pyrrolizidine/ pyrrolothiazole de- rivatives via three component 1,3 - dipolar cycloaddition reactions [J]. ACS Comb Sci, 2014,16(8) :506 -512.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部